DIRAmed
Columbus
About DIRAmed
DIRAmed is developing pain-free, non-invasive meters that accurately measure the levels of key constituents of the human body such as glucose, ketones, cholesterol, and therapeutic drugs. DIRAmed's meters will significantly improve the process by which diabetics and other patients taking therapeutic drugs monitor the levels of important components in their blood and tissue. DIRAmed currently has investigational prototypes in clinical studies for use in improving tight glycemic control in hospital critical care continuous glucose monitoring applications. DIRAmed is also discussing other designs with selected strategic partners including the development of mobile units for personal use with or without connection to an insulin pump.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $295.1K
- Last round: Series Unknown (Jan 2010)
- Website: diramed.com
- Phone: 614-487-3660
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/diramed-1060705 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.